Purchase by Jonathan Anderman (General Counsel)
25,000 shares · @ $1.89 · $47,250
Compass Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $2.22
+11% in 1d after detection
Post-detection moves
1h
—
1d
+11%
3d
+10%
7d
+3.4%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS